Company announcements include a new multifocal lens launch and MiSight study data spanning 7 years
The 2021 American Academy of Optometry (AAO) annual meeting is set to feature new multifocal contact lens introductions from CooperVision.
The company plans to launch the new multifocal lens options on Thursday, November 4 in Boston. The launch will include MyDay, a daily disposable multifocal lens that expands on the CooperVision’s popular 1 day family. It also plans to share key findings from its MiSight 1 day myopia control clinical trial.
“Since springtime, we have heard customers and colleagues saying how much they’ve been looking forward to Academy—for the education, the science, the products, and of course the people,” said Melissa Kiewe, Vice President of Marketing (North America) for CooperVision. “We can’t wait to share how CooperVision innovation and partnerships with the optometry community are taking on presbyopia like never before, slowing the progression of myopia, and helping practices extend and deepen their patient relationships.”
The new, daily disposable, multifocal, soft contact lens, MyDay, is designed for patients with presbyopia. MyDay lenses are the first to feature a new Binocular Progressive System- a breakthrough approach that simplifies fit and provides optimal visual acuity at all levels, according to the company.
During the US launch, CooperVision will debut its companion marketing campaign at its booth. Attendees who stop by will be able to insert themselves into a program called “Game On, Presbyopia”.
CooperVision will also introduce decentered, multi-focal optics for its Onefit and Onefit MED+ scleral contact lenses. These design upgrades include a user-friendly, online fitting tool that allows practitioners to align the multifocal optics to the visual axis.